Rare diseases
Investigational molecules
Locations
Back to Romania71 clinical trials in Constanta, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)Study on Rifamycin SV for Patients with Mild to Moderate Left-Sided Ulcerative Colitis
RomaniaStudy on Lasmiditan for Treating Migraine in Children Aged 6 to 17
RomaniaStudy on the Effectiveness and Safety of Oral Semaglutide Compared to Placebo in Children and Adolescents with Type 2 Diabetes Using Metformin or Basal Insulin
RomaniaStudy on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis
RomaniaStudy on the Effectiveness and Safety of Batoclimab for Adults with Generalized Myasthenia Gravis
RomaniaStudy on the Safety and Tolerability of Lasmiditan for Treating Migraine in Children Aged 6 to 17
RomaniaStudy on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
RomaniaStudy on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients
RomaniaStudy on the Safety and Effectiveness of Bemnifosbuvir and Ruzasvir for Patients with Chronic Hepatitis C
RomaniaStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
RomaniaStudy on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on multiple sclerosis treatments, including studies of remibrutinib and tolebrutinib for both relapsing and progressive forms. Additional trials investigate therapies for myasthenia gravis and chronic inflammatory demyelinating polyneuropathy.
Studies aim to evaluate long-term safety and efficacy of novel therapeutic approaches.
Comprehensive research into viral infections, including studies on COVID-19 treatments and HIV-1 management. Trials evaluate new therapeutic options for respiratory syncytial virus (RSV) prevention in infants.
Focus on developing both treatment and preventive strategies for viral diseases.
Studies investigating treatments for Sjögren's Disease and inflammatory bowel conditions like Crohn's Disease. Research includes evaluation of novel therapies such as mirikizumab and MORF-057.
Trials focus on improving disease management and patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
